~ " The reason is , that t~ effects of pre~ancy or hoemonal manipulation on the pathogenesis and metastatic spread of maligrent melanoma is unclear. On one side the presence of steroid receptors (SR) (E.T. Creagan st al., Cancer Treatment Reports 64, 199, 198o) , estradisl receptors (ER) and progesterone receptors (PgR) (M.Fern5 et al., Anticanoer Research 4, 179, 1984) in melanoma has been reported. On the other side there is no correlation between the detected receptorproteins and the ~ influence on the melanome growth phase. In Literature there is conformity that there is no change in the 5 year survival rate in comparison to non-pregnant females, if the melanoma is diagnosed during pregnancy. An ~mprovement of the 5 year survival rate is described for females with multiple pregnancies before developing a melanoma. A decrease of the 5 year survival rate is found foe pregnant females in stage If, and again there occurs no change in prognosis in case of pregnancy after melanoma excision. All this makes the medical advice foe pregnant females difficult. According to the most important prognostic factor, the tu~a~d~ickness, it is possible to justify the folls~rg procedure: 
ASPECTS OF CON~RAc~ION
IN F~NALE CANCER PAtIENtS W. Sauerwein~ R. Callies~ ~[. Nohlen~ P~ Pregnancies of women with cancer are usually unwanted and may represent a medical, eugenic or psychological problem~ Frequently, contraceptive counseling has been insufficient.Within the last year, 5 unwanted pregnancies were observed in women following completed treatment of either Hodgkin's diseas or breast cancer~ Among an annual q50 female outpatients with various malignant tumors and at risk of pre@-nancy~ the above 5 women represent aclinical i~ cidence of 3.3~ of unwanted pregnancies. One case was due to OC failure and ~ cases occurred for incompetent counseling. Reasons given to the patients for abstaining from contraception were assumed negative influences of hormones upon the malignant condition. Four pregnancies went to term and healthy babies were delivered. One was terminated for psychosocial grounds. Pregnancies of cancer patients after treatment are relatively safe with regard to ma!formatio~ although they should not occur unwantedly for psychological reasons. For these patients,safe contraception is desired, but in contrast is absolutely necessary durin@ cancer treatment. Among the contraceptive methods available, the intrauterine device seems to meet all needs. Barrier contraception with adequate counseling for its use may also be recommended. 0ral contraceptives however, might not be suitable %in suspected hormone dependent tT~mors and 2. when occasional vomiting is expected. Sterilization may be advised in women over 35 years of age. Further studies into this clinical problem should be of value.
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PREGNANCY OUTCOME FOLLOWING CANCER THERAPY M. Rister
Intensive chemo-and radiotherapy cures in many cases malignant diseases. This leads to an increasing number of former cancer patients, who wish to start a family. In a retrospective study we performed a survey among 58 paediatric and 26 obstetric-gynecologic centers as well as a review of the literature to investigate the pre~ nancy outcome after successful treatment for cancer. Following chemotherapy 507 children from 445 former cancer patients have been documented. Only 36 (7%) newborns exhibited abnormalities. In 23 of 120 (19%) children have been observed abnormalities, who descended from 92 patients who had recieved a combined radio-and chemotherapy. Malformations were seen in four of 28 (14%) newborns from parents who were treated for cancer before the onset of puberty. Abnormalities were observed in eight of 84 (9%) children, who descended from parents treated for cancer after the onset of puberty. We observed no special malformation pattern induced by cytostatic drugs or following radiotherapy. The main abnormality documented was prematurity. Since the observed incidence of abnormalities following cancer therapy corresponds to the frequency in a normal population, this study demonstrates no effects of intensive tumor therapy on subsequent newborns.
Thus, at present one year after the cessation of cancer treatment a too pessimistic attitude towards conception does not appear justified from a medical viewpoint.
Universitits-Kinderklinik, Schwanenweg 20, 2300 Kiel I
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PREGNANCY FOLLOWING RADIO-ONCOLOGICAL THERAPY: ASPECTS OF GEN~ZC COUNSELING W. Sauerwein and E. PassarSe Successful radio-oncological therapy allows an increasing number of patients to lead a normal life and become parents. Anxiety results from fear of~ssible mutagenic orteratogenic effects of the previous therapy. On the basis of theoretically possible risks patients are not infrequently advised by physicians to advoid or to terminate pregnancy following cancer therapy~ Between q978 and q985 we re-assessed 30 tumor patients who seeked genetic counseling. They had received radiotherapy (I?), chemotherapy (2) or a combination of both (~I). 19 couples came p~er to pregnancy, 11 during pregnancy, of the latte~ 5 explicitly came to confirm that termination of pregnancy was necessery. Two women had previously terminated a pregnancy for fear of a mutagenic risk to their offspring. In the prior-toconception situations we counseled that cancer therapy would not constitute a recognizable individual mutagenic risk. Thus, a pregnancy could well be considered. We recommended an interval of about 6-~2 months following therapy. Once a pregnancy had occurred, we recommended that it could be continued. In no instance was a child born with congenital developmental defects. In spite of the theoretically expected mutagenio risk of radio-oncologica! therapy, empirical observations do not indicate that such risk exists~ For counseling purposes it appears to be important to distinguish a theoretically possible risk, the demand for formal exclusion of such a risk, and the actual lack of evidence for an increased risk. Strahlenklinik and Institut fdr Humangenetik Universititskliniktm D -4300 Essen
